Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950137-05-003888
Filing Date
2005-03-30
Accepted
2005-03-30 16:17:17
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a07146e10vk.htm 10-K 748278
2 EXHIBIT 23.1 a07146exv23w1.txt EX-23.1 620
3 EXHIBIT 31.1 a07146exv31w1.txt EX-31.1 3821
4 EXHIBIT 31.2 a07146exv31w2.txt EX-31.2 3808
5 EXHIBIT 32 a07146exv32.txt EX-32 1792
6 GRAPHIC a07146a0714600.gif GRAPHIC 102899
7 GRAPHIC a07146a0714601.gif GRAPHIC 61421
  Complete submission text file 0000950137-05-003888.txt   924773
Mailing Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Filer) CIK: 0001128495 (see all company filings)

EIN.: 223193172
Type: 10-K | Act: 34 | File No.: 000-50632 | Film No.: 05714450
SIC: 2834 Pharmaceutical Preparations